Bokf, Na Pacific Biosciences Of California, Inc. Transaction History

Bokf, Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$2.65 - $4.03 $238,884 - $363,284	-90,145 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$2.36 - $5.26 $472,000 - $1.05 Million	-200,000 Reduced 68.93%	90,145 $276,000
Q4 2019 Feb 12, 2020	BUY	$4.6 - $5.57 $81,056 - $98,148	17,621 Added 6.47%	290,145 $1.49 Million
Q3 2019 Nov 13, 2019	SELL	$4.99 - $6.16 $14,860 - $18,344	-2,978 Reduced 1.08%	272,524 $1.41 Million
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $801,633 - $1 Million	135,411 Added 96.66%	275,502 $1.67 Million
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $644,089 - $700,920	94,719 Added 208.76%	140,091 $1.01 Million
Q4 2018 Feb 13, 2019	BUY	$3.99 - $7.82 $181,034 - $354,809	45,372 New	45,372 $335,000

259

256M

3.05M

1.71M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $328M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.